Related by context. All words. (Click for frequent words.) 61 Plicera 59 Sular formulation 59 CORLUX CORT # 59 successfully commercialize Iluvien 59 subsidiaries visit http:/www.apricusbio.com 59 Eligard R 59 IL# PE#QQR 59 Government Qualifying Therapeutic 58 Phase IIa clinical trials 58 NASDAQ GNTA 58 Frova ® 58 Syncria 58 CIP TRAMADOL ER 58 Cutanea Life Sciences 58 MethyPatch 58 NYSE Amex PTN 58 Lamictal ODT 57 Surfaxin LS 57 Multiple Ascending Dose 57 zileuton IV 57 RAPTIVA R 57 markets Testim ® 57 TSX VENTURE PPY.A TSX 57 BLA filing 57 Premarket Approval Application 57 Biologic License Application BLA 57 Inc. Nasdaq VASC 57 Saforis 57 Æterna Zentaris 57 Severe hypersensitivity reactions 57 Initiates Phase II 57 Firdapse 56 Contingent Value Rights 56 MOZOBIL 56 TRACON Pharmaceuticals 56 Inc. Nasdaq SEPR 56 Nasdaq VRTX 56 mifamurtide 56 NASDAQ ENMD 56 Loramyc ™ 56 Exelixis compounds 56 please visit http:/www.atherogenics.com 56 Somatuline Autogel 56 WILEX 56 sumatriptan injection 56 Zavesca ® 56 PentaStaph 56 Increlex TM 56 candidate XP# 56 EHSK 56 Aurvista 56 sNDA filing 56 MAXY alpha 56 NASDAQ DYAX 56 commonstock 56 Cellegesic 56 ENTB 56 Alvesco R 56 AMEX IVX LSE IVX.L 56 Hedgehog antagonist 56 Georox Resources Inc. 56 Emezine 56 Targeted Chemotherapy 56 GLASSIA 56 Nasdaq NPSP announced 56 Lumacan 56 elotuzumab 55 TWYNSTA ® 55 NEBIDO 55 Allovectin 7 55 NeuroSolutions 55 NASDAQ ENZN 55 Gestiva TM 55 Submits Response 55 FDA Approvable Letter 55 Metabasis stockholders 55 VaxGen stockholders 55 Tesmilifene 55 Rotarix R 55 Somatuline Depot 55 FACTIVE tablets 55 XL# anticancer compounds 55 hoFH 55 InterfeRx 55 Nasdaq RXII 55 Committed Equity 55 PROMACTA ® 55 BioGlue ® 55 oral ridaforolimus 55 Orapred ODT 55 ruxolitinib 55 BLA submission 55 CEFF financings subject 55 Phase IIa trials 55 naronapride 55 Nabi HB Intravenous 55 proprietary Capillary Aerosolization Technology 55 RIGScan CR 55 FDA approvable letter 55 indiplon capsules 55 commercialize NicVAX 55 Oracea TM 55 Somatuline R Depot 55 nalbuphine ER 55 OTCBB RDIAF announces 55 Palatin intends 55 GLASSIA ™ 55 NASDAQ BPAX 55 â € œwill â 55 Phenoptin 55 Argatroban 55 manufactures minimally invasive 55 MAb therapy 55 PREOS R 55 Dyloject TM 55 NASDAQ PGNX 55 CAPHOSOL 55 minimally dilutive 55 CapGen Offering 55 Neurogen stockholders 55 HepeX B 55 Eligard ® 55 NASDAQ NOVN 55 iii Cubist 55 XL# XL# XL# XL# 55 CAUTIONARY STATEMENT Statements 55 AeroLEF R 55 liquidating distributions 55 NYSE HTS Hatteras 55 Furiex Pharmaceuticals 55 CDP# 54 liprotamase 54 Aerosurf 54 Stedesa 54 talactoferrin 54 KIACTA TM 54 please visit www.middlebrookpharma.com 54 Biotie 54 Inc. Nasdaq NEOL 54 Solorel TM 54 Intermezzo ® NDA 54 initiate Phase IIb 54 Auxilium anticipates 54 NYSE AMEX PLX 54 VaxImmune 54 severe hypercholesterolemia 54 Aurora kinase inhibitor 54 alogliptin NDA 54 Generx TM 54 HuCAL antibodies 54 Indaflex 54 XERECEPT R 54 GTHP 54 Upfront Payment 54 TAXUS Element Stent System 54 Rescula 54 Trobalt 54 Auric Mining Corp. 54 drug ISA# 54 CLIRS trial 54 markets HP Acthar 54 Inc. Nasdaq CRTX 54 Incentive Warrants 54 Gamunex C 54 NASDAQ REGN 54 please visit www.cpexpharm.com 54 oral taxane 54 Aloprim TM allopurinol sodium 54 MIST II 54 phase IIb trial 54 initiate Phase 1b 54 MAA submission 54 lender consents 54 OTCBB FROI 54 Cinquil 54 TSX VENTURE URO 54 molecular imaging radiopharmaceutical 54 Xerecept 54 TSX VENTURE NML 54 Spiegelmer ® 54 faropenem 54 Anturol TM 54 HuMax CD4 54 EGRIFTA TM 54 BioGeneriX 54 GLP toxicology studies 54 visit http:/www.neogenomics.org 54 PharmaBio 54 GPC Biotech undertakes 54 Repurchase Program 54 Loramyc 54 please visit http:/www.sunesis.com 54 promotes MERREM ® 54 Certican 54 oral methylnaltrexone 54 Visudyne R 54 BCR ABL inhibitors 54 website www.nyandcompany.com 54 Fast Track Status 54 Biological License Application 54 including withoutlimitation 54 Firazyr 54 COLAZAL R 54 plc LSE SHP 53 Inc. NASDAQ ZLCS 53 Complete Response letter 53 Velac 53 Rotarix ® 53 ALN HTT 53 Milestone Payments 53 Harry Palmin President 53 Sanctura XR 53 Solzira 53 Inc. NASDAQ XNPT 53 BiDil XR 53 OLEPTRO 53 CCR9 antagonist 53 Graniz Loan 53 Submits Biologics License Application 53 Receive Milestone Payment 53 Metallic Ventures 53 Acapodene R 53 NASDAQ EPMD 53 Aradigm Corporation OTCBB ARDM 53 NASDAQ MOGN 53 IoGen 53 Valtropin 53 Arana Therapeutics Limited 53 containership charter owner 53 Approvable letter 53 BRILINTA 53 Oracea ® 53 eprodisate KIACTA TM 53 Invicorp R 53 DPX Survivac 53 Flutiform TM 53 ZADAXIN ® 53 REMOXY NDA 53 velaglucerase alfa 53 Allovectin 7 r 53 phase IIa clinical 53 BioGlue R 53 PCA3 test 53 Glassia 53 Zavesca r 53 Sinuwave 53 FOLOTYN ® 53 Zemplar Capsules 53 IGXT IntelGenx today 53 Fanapt ™ 53 TRX1 53 CONBRIZA 53 Xenazine ® 53 involve risksand uncertainties 53 Inc. NASDAQ EVVV 53 shares issuable pursuant 53 Tech DVAX 53 cystinosis patients 53 TOCOSOL Paclitaxel 53 CytoFabTM 53 ARIKACE ™ 53 forward lookinginformation 53 BIOCEUTICALS 53 Pliaglis 53 telaprevir VX 53 BEMA Buprenorphine 53 Preotact 53 Naglazyme R 53 PrevOnco 53 CIMZIA r 53 Dextofisopam 53 CVac 53 HuMax TAC 53 Calixa 53 Ketotransdel 53 REPLAGAL 53 Milestone Payment 53 Phase 1a clinical 53 DiaPep# 53 earnout payments 53 Nasdaq ADLR 53 ZEGERID Capsules 53 omacetaxine mepesuccinate 53 RAPTIVA r 53 UPLYSO 53 Rasilez HCT 53 AMEX TGB Taseko 53 DIFICID ™ 53 Allovectin 7 ® 53 Allovectin 7 R 53 Drug Eluting Stent System 53 ACAPODENE R 53 danoprevir 53 pixantrone NDA 53 EGS# 53 ularitide 53 Premarket Approval PMA 53 BrachySil 53 OncoVEX 53 Astex Therapeutics 52 Bionutrics 52 Zemiva TM 52 TRISENOX ® 52 Amended Agreement 52 NASDAQ IMDC 52 Sandstorm Resources 52 Proellex TM 52 Non Renounceable Rights 52 Plenaxis R 52 Orphan Drug designations 52 NASDAQ LBTYA NASDAQ LBTYB 52 SILENOR TM 52 AXGJ 52 Premarket Approval 52 Synerx 52 Nicotine Conjugate Vaccine 52 Discovery Project QTDP 52 theseforward looking 52 Unit Dose Budesonide 52 Medidur FA 52 AeroLEF TM 52 Urocidin TM 52 NASDAQ TARG 52 Vectibix panitumumab 52 EVLN 52 transfusional iron overload 52 CorNova 52 confirmatory Phase III 52 ENRICH trial 52 Company OTCBB CXDC 52 AkaRx 52 Marketing Authorisation Application 52 BLVT BulovaTech 52 Soliris eculizumab 52 NASDAQ OSIR 52 Retisert 52 Vicor anticipates 52 known teratogen substance 52 OCTI 52 Zenpep 52 Daytrana ® 52 BioOne Corporation 52 Sepracor anticipates 52 EP MedSystems shareholders 52 novel histone deacetylase 52 Synvisc ONE 52 Omigard TM 52 Gestiva ™ 52 ATryn ® 52 OvaRex ® MAb 52 ASX UNS 52 TSX VENTURE ORM 52 NASDAQ PHRM 52 LGND 52 Dermylex TM 52 MONOVISC 52 Axcan Pharma Holding BV 52 FROVA 52 Proquin XR 52 LUCASSIN 52 Optiquel ™ 52 Illumigen 52 GBOE 52 Onsolis 52 Ception 52 Shire BioChem Inc. 52 thedate hereof 52 XIAPEX 52 BEMA Granisetron 52 aresubject 52 Somatuline R Autogel R 52 Cellegy 52 Civacir 52 Poly ICR 52 oral nucleoside analogue 52 ANDA submission 52 bardoxolone 52 TKM Ebola 52 Sanvar R 52 Iluvien ® 52 MEND CABG II 52 balsalazide tablet 52 BioTie 52 Troxatyl 52 Isolagen Process 52 Inc. OTCBB MBCI 52 TSX VENTURE LUC 52 Ixempra 52 Daytrana TM 52 Cutanea 52 Chesstown 52 Trust TSX MMP.UN 52 withrespect 52 Convertible Promissory Note 52 Velcade bortezomib 52 initiate Phase 2b 52 Zolpidem Tartrate Tablets 52 Janssen AI 52 Nasdaq WCRX 52 polymer platinate 52 Laquinimod 52 Aphthasol R 52 Fortical ® 52 QTDP 52 TriPath Oncology 52 Trubion Pharma 52 Contingent Value Right 52 Phase 2a clinical trials 52 adopting SFAS #R 52 ATL# [001] 52 FACTIVE R gemifloxacin 52 ELND# 52 Xoma Ltd 52 dutogliptin 52 share repurchase authorizations 52 Sumatriptan Succinate 52 Orosi Mill project 52 PDE4 inhibitor 52 Gentamicin Surgical Implant 52 AERx iDMS 52 PIX# trial 52 GAMMAGARD 52 Substantial Issuer Bid 52 Announces Tentative Approval 52 Methylphenidate Transdermal System 52 KRYSTEXXA TM pegloticase 52 Novexel 52 Lupuzor 52 Aegerion 52 vernakalant iv 52 Sigma Tau Pharmaceuticals 52 Protox 52 Hectorol R 51 rasagiline tablets 51 regarding Heska 51 G#DT 51 Nio Metals 51 PLAVIX ® 51 Omigard 51 Asentar TM 51 Prodarsan R 51 budesonide MMX Phase III 51 Galderma SA 51 ZEGERID Chewable Tablets 51 Phase IIb clinical trials 51 Gastrotech 51 novel VDA molecule 51 pancreatic enzyme replacement 51 Prednisporin 51 PerClot 51 Warner Chilcott plc 51 CRMD# 51 R pegaptanib sodium 51 AMPK activators 51 Loramyc TM 51 liver resection surgeries 51 label Lipofen R 51 Stavzor 51 Dynogen 51 SNT MC# 51 Aeolus Pharmaceuticals Announces 51 P#X# antagonist 51 Sumavel DosePro 51 Fodosine 51 traunch 51 glucokinase activator 51 Onalta ™ 51 SILENOR 51 miconazole MBT 51 LOI contemplates 51 Evoltra 51 Psivida 51 Orphan Drug designation 51 RAPTIVA 51 Receives Milestone Payment 51 undertake anyobligation 51 Ceplene histamine dihydrochloride 51 Retacrit 51 lumiliximab 51 ELEVESS 51 Vernalis plc 51 GeoVax AIDS vaccine 51 IIa trial 51 L BLP# 51 Matrix Phase 2b 51 orphan designation 51 Zerenex 51 Adjourns Annual Meeting 51 Telephone Replay Will 51 NeuroMedix 51 Nasdaq EXAS today 51 Pennsaid R 51 Partnering Guide 51 Bellus Health 51 Cellgate Inc. 51 TSX VENTURE RDK FRANKFURT 51 CAMPATH 51 ATryn R 51 Alnara Pharmaceuticals 51 ENZON 51 dirucotide 51 Galephar 51 Zeneus 51 www.nexmed.com 51 compound CIP FENOFIBRATE 51 Milestone Payment From 51 Montaur 51 XP# XP# 51 Furiex 51 developing ostarine selective 51 Tekamlo 51 Serica Energy plc Serica 51 Enzon Pharmaceuticals Inc 51 NLTX 51 Flutiform ™ 51 APTIMA HPV assay 51 TASE CAMT 51 AzaSite Plus 51 ADSI cautions 51 Entitlement Issue 51 Potelligent Technology 51 BioDelivery Sciences 51 telavancin NDA 51 Triglide 51 elagolix 51 Monovisc 51 TSX VENTURE RM OTCQX 51 Urocidin 51 License Option Agreement 51 IV APAP 51 outlicensed 51 Sensipar 51 JAK2 inhibitor 51 Reclast Aclasta 51 Investigational Device Exemption 51 ELIQUIS 51 Thermadyne shareholders 51 mutually satisfactory definitive 51 BOWMORE 51 #D#C# 51 http:/www.spectrumpharm.com 51 Dynepo TM 51 XERECEPT 51 Ventrus 51 orBec R 51 LUVENIQ 51 Trubion Pharmaceuticals TRBN 51 NovaDel 51 refractory chronic lymphocytic 51 Inc. NASDAQ ACOR 51 MK #B 51 Asentar 51 T Pred 51 Aclasta Reclast 51 Inc. NASDAQ NEOL 51 RH1 51 www.eatonvance.com closed end tax info.php 51 Toraymyxin TM 51 Corporation GENZ GENZ 51 Sets Record Date 51 BCY 51 NYSE VTR Ventas 51 Addrenex 51 novel MetAP 2 51 miconazole Lauriad R 51 Files Shelf Registration Statement 51 DJOFL 51 SAR# [002] 51 Concurrent Private Placement 51 Lebowa transaction 51 Rhucin ® recombinant 51 Marketing Authorisation 51 Entocort 51 FBPase 51 ZALBIN 51 Apex Bioventures 51 Linjeta TM 51 RTP #i 51 Zentaris 51 deforolimus 51 Dividend Reinvestment Plan DRIP 51 Nycomed GmbH 51 Nasdaq MITI 51 update anyforward looking 51 Kissei Pharmaceutical 51 Cell Genesys stockholders 51 HalcyGen 51 Auxilium assessments 51 Merged Entity 51 Trizytek 51 Calixa Therapeutics 51 Private Placement Offering 51 Egrifta 51 Nasdaq OPTR 51 Rozetta Cell 51 TolerRx 51 elbion 51 Icatibant 51 tramiprosate ALZHEMED TM 51 ABthrax TM 51 DYNV 51 cicletanine 51 Junovan 51 TELINTRA R 51 SURFAXIN 51 TRUSTCASH 51 PrevOnco ™ 51 KIACTA ™ 51 Combidex 51 Prochieve R 51 placebo intravenously 51 NASDAQ CYPB 51 requisite regulatory approvals 51 BioCancell 51 Salmedix 51 SURFAXIN r 51 Oglemilast 51 Corautus 51 BGMO 51 Symphony tCGM System 51 voclosporin 51 HepaGam B 50 Angiox ® 50 commercialize elagolix 50 SOLODYN R 50 Exalgo TM 50 Convertible Loan 50 DIP Loan 50 Inc NGSX 50 Symphony tCGM 50 NASDAQ ACOR 50 DCCR 50 Warner Chilcott Limited 50 LFRP 50 volociximab 50 NASDAQ OGXI 50 Avigen stockholders 50 TSX VENTURE LGF Laurentian 50 ENGINEERING.com Incorporated Announces 50 ONSOLIS 50 Marketing Authorisation Application MAA 50 Sangaredi Refinery Project 50 Inc. NASDAQ ELGX 50 Celmed 50 eTag assays 50 TKM PLK1 50 Sycrest 50 GetGoal Phase III 50 Elevess 50 Amoxicillin PULSYS Phase III 50 SynthRx 50 Paladin Labs 50 consents authorizations 50 Corporation NASDAQ PGIC 50 Solasia 50 Angioblast 50 gastrointestinal disorders ATI 50 Relivar 50 Ondansetron Injection 50 acquire Medafor 50 Orphan Drug Status 50 Chaim Lebovits President 50 incorporate CXA 50 #.#per diluted 50 dacetuzumab collaboration 50 Emselex 50 ASX PGL 50 PRECISE Trial 50 GRN# 50 AnorMED 50 TomoTherapy judgments 50 http:/www.sunesis.com 50 pediatric acute lymphoblastic 50 Acetavance TM 50 THELIN 50 intravenous formulations 50 Gralise 50 Proprius Pharmaceuticals 50 HYVISC R 50 ZCI Offer 50 earnings pershare 50 expressively disclaims 50 AVINZA ® 50 toupdate 50 EPIX Pharmaceuticals 50 Exelon Patch 50 KRYSTEXXA 50 Aloxi Injection 50 LibiGel NDA 50 lucinactant 50 Kynapid 50 TSX PLB leading 50 NeuVax 50 Magma undertakes 50 highly purified pasteurized 50 Removab 50 Arikace 50 generic Copaxone 50 Clevudine 50 Thorough QT 50 Project QTDP program 50 Genz # 50 SILENOR ™ 50 update theseforward looking 50 Nasdaq CRDC 50 EOquin 50 TLR antagonists 50 Phase lll 50 JOULFERON 50 sirtuin modulators 50 inhaled AAT 50 Levoleucovorin 50 refinance indebtedness 50 PharMerica LTC Transaction 50 reflect Ronn Motor 50 EvaMist TM 50 NASDAQ RADA 50 Enpath ability 50 ® natalizumab 50 Lovaza TM 50 CoTherix logo 50 Panzem R NCD 50 brivaracetam 50 NGSX 50 inhaled formulation 50 Geomark 50 Stock Repurchase Plan 50 Sylvie Gregoire President 50 Pyridorin 50 Belinostat 50 Visian Toric ICL 50 MacroChem Corporation 50 Perforomist TM formoterol fumarate 50 REMINYL ® 50 GTCB 50 AnGes MG Inc. 50 hyperimmune products 50 BioMarin Genzyme LLC 50 Pharmos pipeline 50 CEFF 50 ZBx 50 valopicitabine 50 NanoCrystal technology 50 Enlarged Group 50 WSE IVX 50 Sensipar R 50 Gnaweeda Project 50 ACTIQ 50 Kind Tender Offer 50 TWO.WS 50 Prestara 50 MultiCell bases 50 LE SN# 50 Default Status Reports 50 includingstatements regarding 50 Esprit Pharma 50 injectable formulations 50 Loramyc R 50 Synt em 50 Combination Agreement 50 Syntonix 50 NASDAQ INHX 50 sumatriptan DosePro 50 Nascobal ® 50 ASONEP 50 Sebivo 50 Zegerid OTC 50 DMRJ 50 Nasdaq GORX 50 CCX# 50 ASG 5ME 50 Inc. Nasdaq CPRX 50 alvimopan 50 Novadel 50 sargramostim 50 Alnylam Nasdaq ALNY 50 AIMM trial 50 TSX VENTURE LFD 50 Vertex Pharma 50 OTCBB ARDM 50 develop GED aPC 50 REPEL CV 50 ViroChem 50 marginally accretive 50 Dynepo 50 Orally administered 50 quarter# 50 daily bactericidal antibiotic 50 Zingo TM 50 ProQuin XR 50 BENLYSTA ® 50 Xechem Nigeria 50 iChem VELOCITY 50 TSX PWE FRANKFURT 50 Rosebel royalty 50 Kyowa Kirin 50 LEP ETU 50 Inc. Nasdaq SLXA 50 Nascobal 50 commercialize CK # 50 mGluR2 positive 50 Cannasat 50 CEMATRIX 50 TRIST study 50 Company TSXV ARQ 50 www.cellgenesys.com 50 serious cardiovascular thrombotic 50 ViroChem Pharma Inc. 50 bevirimat Study 50 convertible promissory notes 50 underwriting discounts commissions 50 ACTEMRA TM 50 underwriters overallotment option 50 acyclovir Lauriad R 50 sevelamer carbonate 50 developing Zerenex ferric 50 CryoSeal 50 Selling Securityholder 50 Ausam 50 MacroChem 50 apaziquone 50 Lung Rx 50 MEZAVANT 50 Receives Stockholder Approval 50 FIRAZYR 50 TRANSDUR Sufentanil 50 Corlux 50 TSX VENTURE PML BVLAC 49 injectable influenza 49 Commercialization Agreement 49 Cimzia TM 49 Taiho Pharmaceutical 49 TheCompany 49 ANDA filings 49 NASDAQ GEOI 49 Accelerated Share Repurchase 49 initiate Phase IIa 49 molecular chaperone regulation 49 BioSTAR R 49 Soliris TM eculizumab 49 OvaRex R 49 Marketing Authorizations 49 PREOS 49 IPL# 49 Avanir Pharmaceuticals Inc 49 TP# CETi 1 49 Merger Transaction 49 PULSYS 49 Tracleer R 49 KIF6 Genotyping Assay 49 CoStar stent 49 TSX VENTURE DMA 49 treat atrial flutter 49 Ventavis ® 49 Qualified Therapeutic Discovery 49 Eloxatin ® 49 lorcaserin NDA 49 peramivir clinical trials 49 Neuromodulation System 49 cannabinor 49 Humanitarian Device Exemption 49 Phase III LibiGel 49 PentaLyte R 49 Orazol 49 Inc. Nasdaq RNVS 49 REMUNE R 49 plc VGM 49 Eligible unitholders 49 RSUs vest 49 Curacyte 49 Oncoscience AG 49 UVIDEM 49 Akorn Strides 49 Investus 49 BayStreet.ca Research Alert 49 PentaLyte 49 OTC Pinksheets 49 NASDAQ BMTI 49 Evoltra ® 49 AVP #D# 49 Underwritten Offering 49 Pennsaid Plus 49 zileuton CR 49 visit www.solitaireminerals.com 49 Valortim TM 49 Pro forma Adjusted EBITDA 49 Vaccinex 49 vernakalant oral 49 CIP Fenofibrate 49 dasatinib Sprycel 49 TSX VENTURE MDV FRANKFURT 49 ALICO Holdings 49 Closes Private Placements 49 Bioral Amphotericin B 49 Cytopia shareholders 49 Phase #b/#a 49 Troxatyl TM 49 GA GCB 49 anti CD3 monoclonal 49 AMEX TMY 49 symbol ZAOFF 49 BREAKYL 49 Term Loan Facility 49 NASDAQ GS IPAR 49 Perlite Canada inc 49 tropism testing 49 Mandatory Convertible Bonds 49 Junovan TM 49 TRIOLEX HE# APOPTONE HE# 49 CINOD 49 oral calcitonin 49 Drug Submission 49 Total lunar eclipses 49 commercialize telaprevir 49 NASDAQ NMTI 49 #,#,# warrants exercisable 49 aerosolized AAT 49 VANTAS 49 DepoBupivacaine TM 49 Kosan dependence 49 TSX VENTURE ADI 49 topical agent Xantryl 49 Requip XL 49 Nemak transaction 49 HGS ETR2 49 LidoPAIN SP 49 relapsed ALL 49 Arqule 49 Cytokinetics specified 49 cinacalcet HCl 49 valtorcitabine 49 OMNARIS HFA 49 Ascend Therapeutics 49 TSX VENTURE SPQ Spider 49 Fronteer Offer 49 DP VPA 49 Synalloy Corporation Announces 49 BEMA Fentanyl 49 Ateba Resources Inc. 49 vinorelbine emulsion 49 please visit www.PositiveIDCorp.com 49 Innodia Inc. 49 HSR clearance 49 IsoTis stockholders 49 immatics 49 K DOQI guidelines 49 Periostat 49 Ablation Frontiers 49 crolibulin TM 49 bortezomib Velcade 49 Reloxin R 49 subjectto 49 Meritage Pharma 49 crinobulin 49 Amlodipine Besylate Tablets 49 Canvaxin 49 Theforward looking 49 QTinno TM 49 subordinated promissory notes 49 Ascent Therapeutics 49 Fanapt ® 49 Alair System 49 JunJing III 49 unleveraged yield 49 OTC ZEGERID 49 Contingent Consideration 49 earnout provision 49 Rocmec Closes 49 confirmatory Phase 3 49 KRYSTEXXA TM 49 Share Repurchase Plan 49 fexofenadine hydrochloride 49 Preotact R 49 constituteforward looking 49 Resolor 49 Mycograb 49 Danish kroner DKK 49 MBMI Closes 49 bilastine 49 NASDAQ NTII 49 EFAPROXYN 49 assumes noobligation 49 Investigational Device Exemption IDE 49 Suros Surgical 49 Firazyr ® 49 Financing Transactions 49 ELADUR 49 PDL# 49 triphendiol 49 asset monetizations 49 Orphan Designation 49 www.noven.com 49 elvucitabine 49 Revance 49 ACLARA 49 Proposed Qualifying Transaction 49 Domilens 49 Xcellerated T Cells 49 Shelf Registration